193
Views
42
CrossRef citations to date
0
Altmetric
Clinical review

Mycophenolate in dermatology

&
Pages 203-211 | Published online: 12 Jul 2009
 

Abstract

Originally used to treat psoriasis nearly three decades ago, mycophenolic acid, reformulated as mycophenolate mofetil (MMF), has been rediscovered by the world of dermatology. As a relatively well‐tolerated immunosuppressive used in organ transplant recipients, MMF has recently been reported to show promise for several dermatologic conditions, including psoriasis, pemphigus vulgaris, pyoderma gangrenosum, bullous lichen planus, and even connective tissue diseases such as lupus erythematosus and dermatomyositis. Although not intended to be exhaustive, this review discusses MMF with regard to its basic pharmacology, its side effects, and its reported efficacy in a variety of dermatologic indications. Relevant literature was retrieved by a Medline search combining the terms ‘mycophenolate’ or ‘mycophenolic acid’ and ‘skin’ or ‘skin disease’ or a number of specific conditions (‘psoriasis’, ‘dermatitis’, ‘eczema’, ‘pemphigoid’, ‘pemphigus’, ‘vasculitis’, ‘pyoderma gangrenosum’, ‘Crohn's disease’, ‘graft‐versus‐host disease’, ‘lichen planus’). As MMF has only been recently re‐introduced for dermatologic application, the nature of much of the literature is admittedly that of case reports or case series. Nevertheless, the results are sufficiently promising to warrant further larger, control studies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.